Lorazepam
NDC 71610-654, Lorazepam, tablet, from Aphena Pharma Solutions - Tennessee, LLC.
- Product NDC
- 71610-654
- Status
- Listed
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA072926
- DEA schedule
- CIV
curl https://api.healthcare.dev/v1/drugs/ndc/71610-654 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LORAZEPAM.5 mg/1
Pharmacologic classes
Benzodiazepine [EPC]; Benzodiazepines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71610-654-10 | 71610065410 | 10 TABLET in 1 BOTTLE, PLASTIC (71610-654-10) |
| 71610-654-15 | 71610065415 | 15 TABLET in 1 BOTTLE, PLASTIC (71610-654-15) |
| 71610-654-20 | 71610065420 | 20 TABLET in 1 BOTTLE, PLASTIC (71610-654-20) |
| 71610-654-28 | 71610065428 | 28 TABLET in 1 BOTTLE, PLASTIC (71610-654-28) |
| 71610-654-30 | 71610065430 | 30 TABLET in 1 BOTTLE, PLASTIC (71610-654-30) |
| 71610-654-45 | 71610065445 | 45 TABLET in 1 BOTTLE, PLASTIC (71610-654-45) |
| 71610-654-53 | 71610065453 | 60 TABLET in 1 BOTTLE, PLASTIC (71610-654-53) |
| 71610-654-60 | 71610065460 | 90 TABLET in 1 BOTTLE, PLASTIC (71610-654-60) |
| 71610-654-70 | 71610065470 | 120 TABLET in 1 BOTTLE, PLASTIC (71610-654-70) |
| 71610-654-75 | 71610065475 | 150 TABLET in 1 BOTTLE, PLASTIC (71610-654-75) |
| 71610-654-80 | 71610065480 | 180 TABLET in 1 BOTTLE, PLASTIC (71610-654-80) |
| 71610-654-92 | 71610065492 | 270 TABLET in 1 BOTTLE, PLASTIC (71610-654-92) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3c20c89f-c8c3-43b3-837e-da413f449795
Use it
Look up 71610-654 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71610-654 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71610-654. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.